Advances in Exosomes in the Pathogenesis and Diagnosis of Lung Cancer.
10.3779/j.issn.1009-3419.2020.104.18
- Author:
Huanhuan BI
1
;
Dunqiang REN
1
;
Jun ZHANG
1
;
Hongmei WANG
1
Author Information
1. Department of Respiratory and Critical Care Medcine, The Affiliated Hospital of Qingdao University, Qingdao 266000, China.
- Publication Type:Journal Article
- Keywords:
Biomarker;
Diagnosis;
Exosomes;
Lung neoplasms;
Prognosis
- From:
Chinese Journal of Lung Cancer
2020;23(7):589-596
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of lung cancer is high worldwide, and lung cancer is the leading cause of death from malignant tumors in both men and women. Early diagnosis of lung cancer can significantly improve the patient's prognosis. Therefore, searching for specific markers to assist in the early diagnosis of lung cancer is urgent question. Exosomes are nano-sized microvesicles and contain various biomaterial, including nucleic acids, proteins, and lipids. Exosomes are important carriers of these biomaterial, serve important roles in intracellular communications and signal transduction among tissues. Due to its unique enrichment mechanism, it has the stability and specificity as a biomarker. Exosomes are not only involved in the formation of tumor microenvironment and new blood vessels in lung cancer, but also involved in chemotherapy, targeted therapy response and prognosis assessment. Many research advances bring new hope for prolonging the survival of lung cancer patients. This article reviews the value of exosome specific protein and microRNA (miRNA) in lung cancer in the diagnosis and prognosis of lung cancer.
